Skip to content
DataLookout
Menu

ADJUVANT-2NCT06373042

Tirofiban for Successful Endovascular Stroke Thrombectomy

StatusUnknown
PhasePhase 2/3
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since May 2024); last known: Not Yet Recruiting
  2. Minor Collaborators reorderedv2
  3. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

Functional independence
Timeframe: 90 days post-randomization

Secondary (12)

Recanalization on follow-up CTA or MRA
Early neurologic improvement
Level of disability
Excellent outcome
Independent ambulation
Show 7 moreShow less
Health-related quality of life
Long-term of disability level
Health-related quality of life (long-term)
Incidence of symptomatic intracranial hemorrhage (SICH)
Radiologic intracranial hemorrhage rate
Mortality
Incidence of non-hemorrhagic serious adverse events

Arms and interventions

TirofibanExperimental

Intraarterial and intravenous tirofiban

PlaceboPlacebo comparator

Intraarterial and intravenous placebo

Drugs: Intraarterial and intravenous tirofiban, Intraarterial and intravenous placebo